Treating Hypertension with Angiotensin II Receptor Blockers: A Step Ahead of Blood Pressure Reduction?

By Ruilope Luis M.  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 1, 2005-01 ,pp. : 9-15

Adis International

Access to resources Recommend Favorite

Comparative evaluation of angiotensin II receptor blockers on HOMA-R and adiponectin release in hypertensive patients with mild type 2 diabetes

By Tomonaga Osamu  

Diabetology International, Vol. 1, Iss. 2, 2010-12 ,pp. : 93-98

Springer Publishing Company

Access to resources Recommend Favorite

Is New-Onset Diabetes Mellitus Important?: Yes, but...

By Alderman Michael H.  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 1, 2008-01 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Omega 3: Where Do We Stand?

By Versari Daniele   Daghini Elena   Salvetti Guido   Salvetti Antonio  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 4, 2008-01 ,pp. : 225-230

Adis International

Access to resources Recommend Favorite

Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild Hypertension

By TRENKWALDER P.   DAHL K.   LEHTOVIRTA M.   MULDER H.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 57-57

Informa Healthcare

Access to resources Recommend Favorite